Matrix degradation in renal disease
- 1 February 1996
- journal article
- Published by Wiley in Nephrology
- Vol. 2 (1) , 13-23
- https://doi.org/10.1111/j.1440-1797.1996.tb00061.x
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Glomerular metalloprotease activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP)Life Sciences, 1994
- An old enzyme with a new function: purification and characterization of a distinct matrix-degrading metalloproteinase in rat kidney cortex and its identification as meprin.The Journal of cell biology, 1994
- Meprin is predominantly involved in parathyroid hormone degradation by the microvillar membranes of rat kidneyLife Sciences, 1994
- Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.Journal of Clinical Investigation, 1993
- Meprin activity in rats with experimental renal diseaseLife Sciences, 1993
- Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucoseBiochemical and Biophysical Research Communications, 1992
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Proteolytic activity in mouse urine; relationship to the kidney metallo-endopeptidase, meprinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts.The Journal of cell biology, 1988
- Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymesFEBS Letters, 1984